| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/14/2001 | EP1082139A2 CARRIER FOR $i(IN VIVO) DELIVERY OF A THERAPEUTIC AGENT |
| 03/14/2001 | EP1082135A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 03/14/2001 | EP1082132A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082123A1 Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical composition |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082093A1 Anti-germ attachment - composition |
| 03/14/2001 | EP1082012A1 Novel nucleosides having bicyclic sugar moiety |
| 03/14/2001 | EP0803506B1 Process for the preparation of 3-halogenocephem derivatives |
| 03/14/2001 | EP0675730B1 Therapeutic combination containing interferon |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1286985A Externally applied Chinese medicine |
| 03/14/2001 | CN1286984A Chinese herbal medicine preparation for treating nameless sores or boils |
| 03/14/2001 | CN1286977A Production process of xiaoliang cold capsule |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/14/2001 | CN1063080C Ointment for curing onychomycosis and preparing process thereof |
| 03/14/2001 | CN1063079C Liquid agentia for treating superficial fungi diseases |
| 03/14/2001 | CN1063057C Antiviral and antibacterial traditional Chinese medicine compounds preparation |
| 03/14/2001 | CN1063043C Medical preparation for feet |
| 03/14/2001 | CN1063042C Ointment for treating tinea pedis |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201005 Method for inhibiting lymphokine production |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200986 Hemoregulatory compounds |
| 03/13/2001 | US6200985 Rapamycin derivatives |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200977 Pyrimidine derivatives |
| 03/13/2001 | US6200959 Genetic induction of anti-viral immune response and genetic vaccine for filovirus |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200746 Detection of enzyme inhibitor; evaluate kinase phosphorylation in presence and absence of virus, incubate with test compound, monitor decrease in enzyme activity |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200598 Active materials entrapped within liposome interior |
| 03/13/2001 | US6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | US6200577 Anti-herpesviral agents and assays therefor |
| 03/13/2001 | US6200576 Swine vesicular disease virus and mutant strains and preparation process and use thereof |
| 03/13/2001 | US6200575 These new ?inactivated? immunogens can be used to induce active immunization in humans which is capable of preventing or correcting the deregulatory effects which the native proteins from which they are produced may help to produce. |
| 03/13/2001 | US6200011 Fixed-housing aimable-beam spotlight luminaire |
| 03/13/2001 | CA2010934C Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016304A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016278A1 Color safe laundry methods employing zwitterionic formulation components |
| 03/08/2001 | WO2001016183A1 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 03/08/2001 | WO2001016182A2 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016163A2 Peptide mixture and vaccine against a chronic viral infection |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016148A1 Macrolide antibiotics and treatment of pasteurellosis |
| 03/08/2001 | WO2001016145A1 Immunopotentiating compositions |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO2001016091A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 03/08/2001 | WO2001015725A1 Vaccine for the protection of a vertebrate animal against fungal skin infection |
| 03/08/2001 | WO2001015704A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 03/08/2001 | WO2001015695A1 Methods of use of fluoroquinolone compounds against bacteria |
| 03/08/2001 | WO2001015684A2 Antimycotic drug |
| 03/08/2001 | WO2001015680A1 Composition for treatment of infections of humans and animals |
| 03/08/2001 | WO2001015670A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015554A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | WO2000078751A3 Compounds for use in treatment of neurological disorders |
| 03/08/2001 | WO2000071139A3 Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices |
| 03/08/2001 | WO2000062767A3 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057870A3 Viral treatment |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999039704A8 Antibacterial agents |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2382034A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381924A1 Color safe laundry methods employing zwitterionic formulation components |
| 03/08/2001 | CA2381849A1 Antimycotic drug |
| 03/08/2001 | CA2381813A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/07/2001 | EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides |